Who
Marc Gruninger
Director
Company insider
Files Form 4 as: Director, Veraxa Biotech AG.
In numbers
- Trades disclosed
- 2
- Buys
- 2
- Sells
- 0
- Bought
- $9,983
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 27 Oct 2026
- Last trade
- 28 Oct 2026
- Last filed
- 29 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Oct 2026filed 29 Oct 2026 | VRXA Veraxa Biotech AGBiotechnology | SEC FORM 4 Bought | $9,1339,133 at $1.00 | filing |
| 27 Oct 2026filed 29 Oct 2026 | VRXA Veraxa Biotech AGBiotechnology | SEC FORM 4 Bought | $850867 at $0.98 | filing |
News
No headline names them, or the companies they trade most, lately.